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Angiopoietin-1, Angiopoietin-2, and Periostin Levels
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Burcu Tahire Koksal, MD,1 Beril Ozdemir Aydın, MD,2 Agah Tekindal, PhD,3 and Ozlem Yılmaz Ozbek, MD1
Background: Recurrent wheeze (RW) is frequent in preschool children. Wheezing phenotypes, asthma pre-
dictive index (API), and modified API (mAPI) have been described for clinical purposes. Our aim was to
examine whether inflammatory markers including serum angiopoietin (Ang)-1, Ang-2, and periostin levels
differ according to wheezing phenotypes and mAPI.
Materials and Methods: Ninety-eight children who were <4 years of age with history of at least 4 episodes of
wheezing during the past 12 months and 51 age-matched healthy controls were included in the study. Children with
RW were classified according to wheezing phenotypes as episodic viral wheeze or multitrigger wheeze, and positive
or negative mAPI. Blood for Ang-1, Ang-2, and periostin levels was drawn during wheezing episode-free periods.
Results: Atopic children with RW (31.4–34.4 ng/mL) demonstrated higher serum Ang-1 levels than nonatopic
children (16.5–13.8 ng/mL) with RW (P=0.03). When we compared children according to wheezing phenotypes,
we could not find any difference in serum Ang-1, Ang-2, and periostin levels between groups. Children with positive
mAPI showed similar Ang-1, Ang-2, and periostin levels with children having negative API and healthy children.
Conclusions: We have found higher serum Ang-1 levels in atopic children with RW, and this result might be
explained by increased inflammation. The evidence was not strong enough to associate serum Ang-1, Ang-2, or
periostin and asthma in preschool children with RW. However, Ang-1 can be a candidate for investigating its
role in predicting atopic children and diagnosing atopic childhood asthma.
Keywords: angiopoietin, asthma, asthma predictive index, periostin, recurrent bronchiolitis
Introduction
Recurrent wheeze (RW) is frequent in preschoolchildren. One-third of children <3 years of age have at
least 1 wheezing episode before their third birthday and may
develop asthma in later childhood.1,2
RW may be the first clinical sign of asthma in first years of
life, however, which child with RW will have asthma in later
childhood cannot be easily estimated. Wheezing phenotypes
according to symptoms have been described for clinical pur-
poses in preschool children with wheezing disorders as epi-
sodic viral wheeze (EVW) and multitrigger wheeze (MTW).3
Asthma predictive index (API) and modified API (mAPI) for
determining the risk of future asthma in children with RW
were developed.4,5 However, using API, mAPI, and symptom-
based phenotypes may not always help to predict future asth-
ma, and there is also no established biomarker for diagnosis of
childhood asthma in children with RW.
Asthma is a chronic inflammatory disease of airways.
Angiopoietins (Ang) have a key role in regulating inflam-
mation and maintaining homeostasis of endothelial cells. Ang-
1 is an essential mediator of angiogenesis that establishes
vascular integrity and Ang-2 acts as its natural inhibitor. Ang-1
and Ang-2 have been shown to involve in pathogenesis of
asthma.6–8 Periostin is an extracellular matrix protein associ-
ated with Th2 inflammation and upregulated in response to
interleukin (IL)-4 and IL-13. Serum periostin is found to be
correlated with eosinophilic airway inflammation and related
with pediatric asthma.9,10
Researches for finding biomarkers to diagnose asthma in
early childhood particularly in children with RW attract at-
tention.11,12 Our aim was to examine serum Ang-1, Ang-2, and
periostin levels in children with RW, and demonstrate whether
Ang-1, Ang-2, and periostin differ according to wheezing
phenotypes and mAPI.
Materials and Methods
Children who were <4 years of age with the history of at
least 4 episodes of wheezing during the past 12 months were
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included in the study. Children with RW were enrolled from
outpatient clinics of pediatric allergy unit and pediatrics
department, and healthy children were enrolled from out-
patient clinics of pediatrics department. At the time of visits,
all the children underwent clinical examination and parents
were asked whether their child had any history of allergic
disease and physician-diagnosed RW. Parents of the child
with RW were also asked about the presence of symptoms in
episode-free periods, age at first wheeze, frequency of wheez-
ing during past 12 months, and night symptoms, asthma
symptoms, and short acting b2-agonist need in a week during
the past month. Wheezing episodes were diagnosed by a gen-
eral pediatrician or a pediatric allergist.
Characteristics of subjects with RW and age-matched
healthy controls were compared. Children who had wheez-
ing episode and/or systemic steroid treatment at the time of
evaluation or during the past 3 months were excluded from
the RW group. Subjects with any allergic disease, history of
asthma symptoms, allergic rhinitis symptoms, or wheezing
episode were excluded from the control group. Children
were further classified according to wheezing phenotypes.
Children who had wheezing only during viral colds and had
no symptoms between wheezing episodes were included in
the EVW group. Children who had wheezing not only with
viral colds but also between wheezing episodes and with
other triggers, including allergens, cold air, cigarette smoke,
exercise, crying, or laughter, were included in MTW group.
We also compared subjects with RW according to mAPI.
mAPI was considered as positive when 1 major or 2 minor
clinical criteria were present in children with RW.5 The major
criteria include parental history of asthma, physician-diagnosed
atopic dermatitis, and allergic sensitization to at least 1 aero-
allergen. The minor criteria include wheezing unrelated to
colds, peripheral blood eosinophils ‡4%, and allergic sensiti-
zation to food(s). Children who had allergy to aeroallergens
and/or food(s) according to skin prick tests or serum tests were
defined as atopic. Results of epidermal skin prick tests, specific
IgE to cow’s milk and hen’s egg, and complete blood counts
were obtained from the medical records. Epidermal skin prick
tests for Dermatophagoides farinae, Dermatophagoides pter-
onyssinus, Alternaria alternata, Cladosporium herbarum, As-
pergillus fumigatus, grass mix, tree mix, weed mix, cereal mix,
and cat were performed.
Blood was drawn during wheezing episode-free periods.
Blood samples were obtained from all participants and were
stored at -80C. Serum Ang-1, Ang-2, and periostin levels
were measured by ELISA (Cusabio) according to manufac-
turer’s instructions. The minimum detection limits for Ang-1,
Ang-2, and periostin were 0.091, 0.31, and 1.56 ng/mL, re-
spectively.
Written informed consent was obtained from all parents
before the study.
Statistical analysis
The results of tests are expressed as the number of ob-
servations (n), mean– standard deviation, median, and min-
max values. Shapiro–Wilk’s test was used to assess the
normality of distributions of the variables, and Levene’s test
was used to assess the homogeneity of variances between
groups. If parametric test assumptions were available, 2
normally distributed independent groups were compared by
Student’s t-test and correlations between variables were an-
alyzed by Pearson correlation coefficient. If parametric test
assumptionswere not available, for comparison of 2 independent
groupsMann–WhitneyU test was used and correlations between
variables were analyzed by Spearman’s r correlation coefficient.
Three or more groups were compared by Analysis of
Variance and Tukey HSD (Honest significant difference)
multiple comparison tests. If parametric test assumptions
were not available, comparisons of 3 independent groups
were performed by Kruskal–Wallis test or Bonferroni–Dunn
test. Categorical data were analyzed with Fisher’s exact test
and w2 test. The exact and Monte Carlo methods provide
means for obtaining accurate results when the data fail to
meet any of the underlying assumptions necessary for reliable
results using the standard asymptotic method. All statistical
analyses were performed with the SPSS software (IBM Corp.
Released 2011. IBM SPSS Statistics for Windows, Version
20.0. Armonk, NY: IBM Corp.) P value of <0.05 was con-
sidered as statistically significant.
Results
Ninety-eight children (47 EVW and 51 MTW) with RW
and age-matched 51 healthy children were included in the
study. Characteristics of participants are presented in Table 1.
Serum Ang-1, Ang-2, periostin levels, and Ang-1/Ang-2
ratio did not show any difference between RW and control
groups (Table 1).
Thirteen children with EVWand 38 children withMTWhad
positive mAPI. When we compared children according to
wheezing phenotypes, we could not find any difference in serum
Ang-1, Ang-2, periostin levels, and Ang-1/Ang-2 ratio between
groups (Table 2). Children with positive mAPI had no differ-
ence in Ang-1, Ang-2, periostin levels, and Ang-1/Ang-2 ratio
compared with children with negative API (Table 3).
Atopic children with RW (31.4– 34.4 pg/mL) demon-
strated higher levels of serum Ang-1 than nonatopic children
with RW (16.5 – 13.8 pg/mL) (P = 0.03) (Fig. 1). There was
no significant difference in serum Ang-2 (13 – 8.3 pg/mL
versus 10.7– 9 pg/mL) and periostin (108.7 – 113.6 ng/mL
versus 88.5 – 74.7 ng/mL) levels between atopic and non-
atopic children with RW (Table 4).
Frequency of treatment using children was higher in MTW
(68.4%) than in EVW (31.6%) group (P= 0.01). Thirty-eight
children (12 EVW, 26 MTW) were receiving continuous
treatment with inhaled steroid and/or montelukast. Children
with positive API (73.7%) had more frequent treatment than
children with negative API (26.3%) (P= 0.04).
Eighteen patients had a high (>400 cells/mL) peripheral
eosinophil count. Ang-1, Ang-2, and periostin levels were
similar between children with high (>400 cells/mL) and low
(<400 cells/mL) peripheral eosinophil counts.
Frequency of RW, EVW, or positive API was higher in
boys than girls (P< 0.01, P < 0.001, P < 0.01, respectively).
Serum Ang-1, Ang-2, and periostin levels showed no as-
sociation with gender in either RW or control groups.
Age at first wheeze was lower in EVW (9.5– 6.9 months)
than in MTW (15.5– 8.9 months) group (P< 0.001) (Table 2).
Frequency of days with asthma symptoms in a week during
pastmonth was positively correlatedwithAng-1 levels (r:0.35,
P< 0.05). No significant correlations were observed between
Ang-1, Ang-2, periostin levels, and duration of disease, age
at first wheeze, or frequency of wheezing during the past 12
months.
ANGIOPOIETINS AND PERIOSTIN IN RECURRENT WHEEZE 231
D
ow
nl
oa
de
d 
by
 B
as
ke
nt
 U
ni
ve
rs
ity
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
4/
25
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Discussion
Diagnosing asthma and deciding to start control treatment
for children with RW <4 years of age can be difficult for
clinicians in daily practice. API, mAPI, and phenotypes in-
cluding EVW and MTW have been described for this purpose.
The identification of biomarkers of childhood asthma is an
active area of research.13 In this study, we wanted to examine
serum Ang-1, Ang-2, and periostin levels in children with RW
during symptom-free periods and we also wondered whether
Ang-1, Ang-2, and periostin levels help to guide clinicians for
diagnosing pediatric asthma. Our data indicated higher Ang-1
Table 2. Characteristics of Children with Episodic Viral Wheeze, Multitrigger Wheeze,
and Healthy Subjects
Episodic viral wheeze Multitrigger wheeze Control P
Male/female 36/11 31/20 25/26
Age (year) 2.5 – 1 2.7 – 0.8 2.5 – 1 0.26
Duration of disease (month) 19.3– 9.8 17.2 – 8.7 — 0.29
Age at first wheeze (month) 9.5 – 6.9 15.5 – 8.9 — <0.001
Frequency of wheezing during past 12 months 4.3 – 1.3 4.5 – 1.4 — 0.32
Night symptoms in a week (day) 1.6 – 1.3 3.1 – 1.7 — 0.005
Asthma symptoms in a week (day) 2.7 – 1.4 3.4 – 1.4 — 0.16
SABA need in a week 2.3 – 1.2 2.7 – 1 — 0.24
Atopy 6 (13) 36 (70.6) — 0.001
API (+) 13 38 —
API score
0 34 12 — 0.001
1 11 26 —
‡2 2 12 —
Hb (g/dL) 12– 1 12.1 – 1 12.2– 1 0.51
Leukocyte (103/mL) 10,386– 3,258 13,419– 29,918 9,669– 2,538 0.53
Total eosinophil count (cells/mL) 244.7– 174.7 261.2 – 212.4 231– 200.9 0.75
Eosinophil (%) 2.5 – 1.6 2.7 – 2.1 2.5 – 2.2 0.82
Thrombocyte (103/mL) 333,872– 109,115 355,960– 115,520 300,060– 72,808 0.02
CRP (mg/L) 5.7 – 10.4 3.5 – 6.4 — 0.13
1.6 (6.5) 1.7 (3.3)
Ang-1 (ng/mL) 23.1– 22.6 31– 32.6 20.3– 16.3 0.08
16.9 (22.9)a 24.8 (39.7)a 17.9 (26.2)a
Ang-2 (ng/mL) 12.9– 10.6 13– 9.8 10.2– 8.7 0.25
9.2 (12.1)a 9.8 (12)a 7.3 (8.4)a
Ang-1/Ang-2 3.1 – 5.6 2.9 – 3.9 3.1 – 3.1 0.92
Periostin (ng/mL) 107.6– 97 112.5 – 107.7 105.4– 120.2 0.95
64.5 (111.6) 71.6 (124.4) 58.7 (97.8)
Values are mean – SD or number (%) unless otherwise indicated.
aMedian (IQR) value.
Ang, angiopoietin; API, asthma predictive index; CRP, C-reactive protein; Hb, hemoglobin; IQR, interquartile range; SD, standard
deviation.
Table 1. Characteristics of Children with Recurrent Wheeze and Healthy Subjects
Recurrent wheezing Control P
Male/female 67/31 25/26
Age (year) 2.6 – 0.9 2.5 – 1 0.39
Hemoglobin (g/dL) 12.1 – 0.5 12.2 – 1 0.32
Leukocyte (103/mL) 11,950 – 21,547 9,669 – 2,538 0.46
Total eosinophil count (cells/mL) 253 – 194 231 – 200.9 0.52
Eosinophil (%) 2.6 – 1.9 2.5 – 2.2 0.77
Thrombocyte (103/mL) 345,258 – 112,426 300,060 – 72,808 0.01
CRP (mg/L) 4.6 – 8.6 11.1 – 22.6 0.22
Ang-1 (ng/mL) 27.2 – 28.4 20.3 – 16.3 0.11
18.7 (31.4)a 17.96 (26.2)a
Ang-2 (ng/mL) 13 – 10.1 10.2 – 8.7 0.09
9.35 (11.7)a 7.3 (8.4)a
Ang-1/Ang-2 3.04 – 4.8 3.1 – 3.1 0,95
Periostin (ng/mL) 110.2 – 102.2 105.4 – 120.2 0.79
69.2 (117.9)a 58.7 (97.8)a
Values are mean – SD unless otherwise indicated.
aMedian (IQR) value.
Ang, angiopoietin; CRP, C-reactive protein; IQR, interquartile range; SD, standard deviation.
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levels in atopic children with RW than in nonatopic children
with RW. This result allows us to suggest that Ang-1 can be a
candidate for investigating its role in diagnosing atopic child-
hood asthma.
Children with a positive API or mAPI are at increased risk
of developing asthma. A stringent API has been statistically
validated as a clinical tool for asthma prediction.4 So that we
have chosen children with at least 4 episodes of wheezing
during the past year. Ang-2 and periostin levels did not show
any difference between groups. However, Ang-1 levels were
higher in atopic children with RW than in nonatopic whee-
zers, and frequency of days with asthma symptoms in a week
during the past month was also positively correlated with
Ang-1 levels. Although statistically not significant, Ang-1
level was higher in the MTW group than in the EVW group
and it was also higher in the API positive group than in the
API negative group. All of these results may support the
notion that Ang-1 is related to inflammation. We believe that
future studies including higher number of children with RW
may also show significant results between MTW and ETW or
between positive API and negative API groups.
Ang-1 and Ang-2 are involved in the pathogenesis of
asthma.14,15 Ang-1 protects against microvascular leakage and
has anti-inflammatory properties.16 Simoes et al. proposed that
Ang-1 levels may rise to provide vascular integrity.6 We think
that Ang-1 levels may remain high to protect vascular integ-
rity and decrease inflammation, particularly in atopic children
with RW. Since Ang-1 is an anti-inflammatory and protective
protein, when inflammation increases, Ang-1 levels may also
increase to protect airways. Moon et al. demonstrated higher
serum Ang-1 levels in patients with asthma and suggested that
Ang are useful markers for the diagnosis of asthma.8 Since
children with atopy and positive mAPI have more risk to
develop asthma, our data may also support these results.
In our previous study, we found that children with asthma
had lower serum Ang-1 levels than healthy children.7 Those
children had stable asthma and were using inhaled steroid
treatment. We think that Ang-1 levels may fluctuate according
to use of asthma medication and asthma control levels. Since
Ang-1 is a protective protein, in earlier childhood Ang-1
levels may increase in wheezy children who will develop
asthma in later childhood.
Higher serum Ang-1 levels may indicate inflammation and
asthma in children. However, serum Ang-2 and periostin do
not seem to help in predicting childhood asthma. As a con-
sequence of choosing children who did not have wheezing
episode or systemic corticosteroid treatment at the time of
evaluation and during the past 3 months, Ang-2 and periostin
levels may have showed similar results with healthy controls
in our study. We think that Ang-2 and periostin levels return
to normal levels when the inflammation is under control and
Table 3. Characteristics of Children with Positive and Negative Asthma Predictive Index
API (+) API (-) Control P
Male/female 40/17 30/11 25/26
Age (year) 2.6 – 0.9 2.6 – 1 2.5 – 1 0.66
First wheezing episode (month) 13.6 – 8.6 11.3 – 8.5 — 0.38
Duration of disease (month) 17.7 – 9 18.9 – 9.7 — 0.82
Ang-1 (ng/mL) 30.7 – 32.4 22.6 – 21.5 20.2 – 16.1 0.07
16.9 (22.9)a 24.8 (39.7)a 17.9 (26.2)a
Ang-2 (ng/mL) 12.6 – 8.4 13.5 – 12.4 10.3 – 8.7 0.26
9.2 (12.1)a 9.8 (12)a 7.3 (8.4)a
Ang-1/Ang-2 2.9 – 3.5 3.3 – 6.3 3.1 – 3.1 0.58
Periostin (ng/mL) 112.3– 104.2 102.9 – 93.1 108.6 – 123.7 0.92
64.5 (111.6)a 71.6 (124.4)a 58.7 (97.8)a
Values are mean – SD unless otherwise indicated.
aMedian (IQR) value.
Ang, angiopoietin; API, asthma predictive index; IQR, interquartile range; SD, standard deviation.
FIG. 1. Comparison of serum Ang-1 levels between ato-
pic and nonatopic subjects. Ang, angiopoietin.
Table 4. Angiopoietin-1, Angiopoietin-2, Ang-1/
Ang-2 Ratio, and Periostin Levels of Wheezy
Children With Atopy and Without Atopy
Atopy (+) Atopy (-) P
n 42 13
Ang-1 (ng/mL) 31.4– 34.4 16.5– 13.8 0.03
22.99 (38.62)a 11.7 (18.05)a
Ang-2 (ng/mL) 13– 8.3 10.7– 9 0.38
11 (11.69)a 7.5 (4.7)a
Ang-1/Ang-2 2.9 – 3.97 1.9 – 1.87 0.41
Periostin (ng/mL) 108.7– 113.6 88.5– 74.7 0.55
62.8 (112.3)a 61 (95.6)a
Values are shown as mean– SD and amedian (IQR).
Ang, angiopoietin; IQR, interquartile range; SD, standard devi-
ation.
ANGIOPOIETINS AND PERIOSTIN IN RECURRENT WHEEZE 233
D
ow
nl
oa
de
d 
by
 B
as
ke
nt
 U
ni
ve
rs
ity
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
4/
25
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
during wheezing episode-free periods. For definite results,
future studies including wheezing episodes and prospective
follow-up of the children with RW are needed to show which
patients will develop asthma.
Lee et al. showed increased circulating Ang-2 in patients
with exacerbated asthma, and their results suggested that
Ang-2 levels are decreased to recruit inflammatory cells
leading to less severe airway obstruction.14 Ang-2 is stored
in Weibel-Palade bodies predominantly in the cytoplasm of
endothelial cells and quickly secreted when needed. Plasma
Ang-2 levels were correlated with blood eosinophil propor-
tions and with the severity of airway occlusion.14 Since our
patients had no wheezing episode at the time of evaluation
and small number of patients had high eosinophil counts, we
may have found similar Ang-2 levels with controls.
Periostin has also been shown to be involved in allergic
inflammation, and periostin levels were found higher in
children with asthma than in healthy controls.17–19 In our
study, we could not find a difference in periostin levels
between EVW and MTW phenotypes or between children
with positive and negative mAPI. Similar to our study,
Castro-Rodriguez et al. found that serum periostin is not
related to API.20 Since we could not show any difference in
periostin levels between groups, we think that periostin is
not helpful in diagnosing early childhood asthma during
wheezing episode-free periods. We consider that periostin
would guide the clinicians to diagnose asthma in children
with older ages or adults. In contrast, periostin seems to be a
reliable protein to determine eosinophilic asthma. A signifi-
cant correlation has been demonstrated between periostin
and blood eosinophil counts.18,19 In our study, only 18 pa-
tients had a high peripheral eosinophil count. We may have
found similar periostin levels between groups due to small
number of patients with a high peripheral eosinophil count.
Inogue et al. suggested that measuring serum periostin,
FeNO, and eosinophils could improve diagnosis of asth-
ma.10 Anderson et al. described that high periostin levels
(>150 ng/mL) and high eosinophil counts (>300 cells/mL) at
the age of 2 years may predict future asthma at the age of 6
years.21 We believe that as long as new cutoff levels of
biomarkers for different ages are described, we will be able
to predict later childhood asthma. Future prospective studies
in which periostin levels will be measured in different age
groups will shed light on this subject.
Our work is the first study examining Ang-1 and Ang-2
levels in children with RW. We have chosen children with
frequent wheeze that would support asthma, and we evalu-
ated children with positive mAPI. Our results referred to
atopy, but not asthma. Ang-1 might be used to detect atopic
children <4 years of age. Limitations of our study are in-
cluding limited population and relying on clinical criteria of
positive API and wheezing phenotypes. A longitidunal study
would be performed to evaluate how many wheezers with
elevated inflammatory markers will develop asthma.
In conclusion, we showed that serum Ang-1 levels were
higher in atopic children with RW than in nonatopic chil-
dren with RW. Since we have found higher serum Ang-1
levels in atopic children, this result might be explained by
increased inflammation. The evidence was not strong en-
ough to associate serum Ang-1, Ang-2, or periostin and
asthma in preschool children with RW. However, serum
Ang-1 may help to predict atopy and diagnose asthma,
particularly in atopic children with RW. Further studies with
longitudinal design, including children with different age
groups and different disease states, are needed to understand
the roles of Ang and periostin in children with RW.
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